Online Only Articles

The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells

Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Italy
Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Italy
Laboratorio di Oncologia, Istituto Giannina Gaslini, Genova, Italy
Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Italy
INSERM, U892, University of Nantes, CNRS, UMR 6299, France
Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Italy
Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Italy
Pathologic Anatomy and Histology, “Azienda Ospedaliero-Universitaria” of Parma, Italy
Pathologic Anatomy and Histology, “Azienda Ospedaliero-Universitaria” of Parma, Italy
Pathologic Anatomy and Histology, “Azienda Ospedaliero-Universitaria” of Parma, Italy
Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Italy
Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Italy;Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy
Department of Medical-Veterinary Science, University of Parma, Italy
Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Italy
INSERM, U892, University of Nantes, CNRS, UMR 6299, France
Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Italy
Vol. 101 No. 3 (2016): March, 2016 https://doi.org/10.3324/haematol.2015.133736